Clinical Significance of the Detection of Antinuclear Antibodies in Patients with Acute Hepatitis A
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Lee, Kwang Gyun | - |
dc.contributor.author | Jung, Eun Suk | - |
dc.contributor.author | An, Hyonggin | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Yeon, Jong Eun | - |
dc.contributor.author | Byun, Kwan Soo | - |
dc.contributor.author | Yim, Hyung Joon | - |
dc.contributor.author | Lee, Hong Sik | - |
dc.contributor.author | Um, Soon Ho | - |
dc.contributor.author | Kim, Chang Duck | - |
dc.contributor.author | Ryu, Ho Sang | - |
dc.date.accessioned | 2022-01-03T07:40:43Z | - |
dc.date.available | 2022-01-03T07:40:43Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2011-09 | - |
dc.identifier.issn | 1976-2283 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/134218 | - |
dc.description.abstract | Background/Aims: The findings of several recent studies suggest that antinuclear antibodies (ANAs) are frequently detected in patients with acute hepatitis A (AHA). However, the clinical significance of a positive ANA test remains uncertain. This study was performed to evaluate the clinical significance of ANAs in AHA patients. Methods: All patients admitted with AHA were consecutively enrolled in this study. An ANA assay was performed by indirect immunofluorescence during hospitalization. ANA positivity was defined as an ANA titer The peak international normalized ratio (INR), peak alanine aminotransferase (ALT) and peak bilirubin levels were assessed over the duration of the hospitalization, and the incidence of AHA complications was evaluated. Results: A total of 422 patients were enrolled in this study (age, 31 7 years), of which 260 (61.6%) were men. ANAs were detected in 179 AHA patients (42.4%). The proportion of ANA-positive patients varied significantly with AHA status on the day of the ANA assay (4.7% during the prodromal period vs 52.1% during the icteric or recovery period, p<0.001) and sex (56.2% in women vs 33.8% in men, p<0.001). The ANAs became un-detectable in all ANA-positive patients within 3 months. The incidence of complications, including mortality, fulminant hepatic failure, renal dysfunction, relapse, and cholestatic hepatitis, did not differ significantly between ANA-positive and ANA-negative patients. Conclusions: ANAs were detected frequently and transiently in patients with AHA, especially after their peak-ALT day. The presence of ANAs may not be associated with the clinical outcome of AHA, but simply with AHA status on the ANA assay day. (Gut Liver 20115:340-347) | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | EDITORIAL OFFICE GUT & LIVER | - |
dc.subject | ORGAN-SPECIFIC AUTOANTIBODIES | - |
dc.subject | SMOOTH-MUSCLE ANTIBODIES | - |
dc.subject | C VIRUS-INFECTION | - |
dc.subject | AUTOIMMUNE HEPATITIS | - |
dc.subject | DISEASE PROFILE | - |
dc.subject | IMPACT | - |
dc.subject | INDIVIDUALS | - |
dc.subject | PREVALENCE | - |
dc.title | Clinical Significance of the Detection of Antinuclear Antibodies in Patients with Acute Hepatitis A | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Yeon Seok | - |
dc.contributor.affiliatedAuthor | An, Hyonggin | - |
dc.contributor.affiliatedAuthor | Kim, Ji Hoon | - |
dc.contributor.affiliatedAuthor | Yeon, Jong Eun | - |
dc.contributor.affiliatedAuthor | Byun, Kwan Soo | - |
dc.contributor.affiliatedAuthor | Yim, Hyung Joon | - |
dc.contributor.affiliatedAuthor | Lee, Hong Sik | - |
dc.contributor.affiliatedAuthor | Um, Soon Ho | - |
dc.contributor.affiliatedAuthor | Kim, Chang Duck | - |
dc.contributor.affiliatedAuthor | Ryu, Ho Sang | - |
dc.identifier.doi | 10.5009/gnl.2011.5.3.340 | - |
dc.identifier.scopusid | 2-s2.0-80052474791 | - |
dc.identifier.wosid | 000294104800013 | - |
dc.identifier.bibliographicCitation | GUT AND LIVER, v.5, no.3, pp.340 - 347 | - |
dc.relation.isPartOf | GUT AND LIVER | - |
dc.citation.title | GUT AND LIVER | - |
dc.citation.volume | 5 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 340 | - |
dc.citation.endPage | 347 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001587872 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | ORGAN-SPECIFIC AUTOANTIBODIES | - |
dc.subject.keywordPlus | SMOOTH-MUSCLE ANTIBODIES | - |
dc.subject.keywordPlus | C VIRUS-INFECTION | - |
dc.subject.keywordPlus | AUTOIMMUNE HEPATITIS | - |
dc.subject.keywordPlus | DISEASE PROFILE | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | INDIVIDUALS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordAuthor | Autoimmune | - |
dc.subject.keywordAuthor | Hepatitis A | - |
dc.subject.keywordAuthor | Clinical outcome | - |
dc.subject.keywordAuthor | Complication | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.